|
|
ED Treatment
Swine Flu Treatment
Recently Added
Recent News
03/10/10 Symmetry Medical reports gross profit of .0M for fourth-quarter 2009
03/10/10 Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM 03/10/10 Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures Top Category's Bestsellers
Antiviral AgentsViral infections are treated by a special type of drugs called antiviral agents. Unique antiviral agents are used to treat different types of viral infestation. Antiviral agents should not be mistaken with viricides. The largest quantity of antiviral agents drugs nowadays are made to fight the HIV or AIDS virus, herpes virus, influenza viruses, hepatitis A,B,C viruses. The effectiveness of some means are significant but some still need a more sophisticated approach. To understand how antiviral agents medications work we need to know the stages of viral development:
The possible stages that can be affected by antiviral agents are:
Viral infestations are very serious and should be treated with appropriate antiviral agents drugs and should not be mistaken with microbial infection. Category News
06/21/07 - BioCryst Presents Phase I Peramivir Data At The Options For The Control Of Influenza Conference
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) presented results from two Phase I clinical studies of an intramuscular (i.m.) formulation of peramivir at the Options for the Control of Influen...
05/07/07 - St. Jude Study Shows Effectiveness Of Peramivir In Prevention Of Mortality In Mouse Model Of Avian Influenza H5N1 Virus Infection
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatmen...
10/04/06 - BioCryst Announces Presentation Of Data Supporting Development Of Peramivir For Seasonal And Life-Threatening Influenza
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today reported positive results from human clinical studies of the influenza neuraminidase inhibitor, peramivir being developed for the treatment of... |